Barrett & Company’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295 | Hold |
300
| – | – | ﹤0.01% | 628 |
|
|
2025
Q1 | $432 | Hold |
300
| – | – | ﹤0.01% | 605 |
|
|
2024
Q4 | $660 | Hold |
300
| – | – | ﹤0.01% | 590 |
|
|
2024
Q3 | $495 | Hold |
300
| – | – | ﹤0.01% | 564 |
|
|
2024
Q2 | $666 | Hold |
300
| – | – | ﹤0.01% | 573 |
|
|
2024
Q1 | $804 | Hold |
300
| – | – | ﹤0.01% | 583 |
|
|
2023
Q4 | $897 | Hold |
300
| – | – | ﹤0.01% | 572 |
|
|
2023
Q3 | $294 | Hold |
300
| – | – | ﹤0.01% | 608 |
|
|
2023
Q2 | $417 | Hold |
300
| – | – | ﹤0.01% | 584 |
|
|
2023
Q1 | $477 | Hold |
300
| – | – | ﹤0.01% | 566 |
|
|
2022
Q4 | $1.87K | Hold |
300
| – | – | ﹤0.01% | 519 |
|
|
2022
Q3 | $1.87K | Buy |
+300
| New | +$1.87K | ﹤0.01% | 519 |
|